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There is general agreement that androgens
mediate the enlargement of the sebaeeous glands
which occurs at puberty (1, 2). Recent experi-
mental and clinical observations indicate a
similar activity for progesterone (3—8). This
question has great importance in understanding
the pathogenesis of acne vulgaris in the female.
The present paper describes the effect of natural
and synthetic progestational agents on sebaceous
gland function.
pHySIoLoGY AND BIOCHEMISTRY OF
PROGESTERONE (9—10)
Progesterone is the product of the ovarian
corpus luteum. It is responsible for the trans-
formation of the estrogen-primed proliferative
uterine endometrium into a secretory type. It not
only is essential for conception but for the
maintenance of pregnancy. In animals, progesta-
tional activity is assayed by the ability to convert
the proliferative uterine mucosa into a secretory
type. In addition, other assays are based upon
the maintenance of pregnancies in oophorecto-
mized animals.
In the human, progestational activity is
determined by histologic study of the endo-
metrium and by measurement of urinary preg-
nandiol, the major known end-product of proges-
terone. There are cyclic rises in the amount of
urinary pregnandiol in the urine of ovulating
females in association with the formation and
involution of the corpus luteum. After the exo-
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genous administration of progesterone, about
10—20% is recovered as urinary pregnandiol.
These findings, coupled with the known
pregnandiol excretion of normal women indicates
that the daily endogenous production of proges-
terone is of the order of 50 to 100 milligrams.
There is increasing evidence that progesterone
may be an intermediate in tbe physiologic
synthesis of other steroids, namely estrogens,
androgens, and corticosteroids. It is possible,
therefore, that progestins, especially in high
doses, may have mixed hormonal effects. It is
the androgenic notentiality of progesterone whieh.i
is the focus of this study. In this connection there
is an extraordinary similarity in chemical
structure; testosterone and progesterone differ
only in the side chain at the 17 position (Figure
1). Indeed, in vitro experiments have demon-
cH3
Testosterone
FTG. 1. Structural formula of progesterone and
testosterone. The only difference is in the side
chain at the 17 position.
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strated that
progesterone by human ovarian tissue (11),
human interstitial cell carcinoma of the testicle
(12), and rat testicles (13). However, neither in
7 humans nor animals does pqflra1 progesterone(
\extremelyhighiiiipplysjpjpgedpses. Definite
increase in the weight of the ventral prostate
gland and seminal vesieles has followed the
administration of large amounts of progesterone
to rats (14—17).
The synthetic progestins are now in vogue
because natural progesterone has a short period
of activity and has to be given intramuscularly.
While the effect of these new synthetic
qgs is progestationa unwanted an rogenie
effects in humans have been iideflThh
91Qk'8, 19). For example, varying degrees of
pseudohermaphrodism have been observed in
thirty-five female infants born of mothers
receiving 17-alpha-ethynyl-1 9-nortestosterone
during their pregnancies (19). One investi-
gator found pseudohermaphrodism in seventeen
of fifty-three infants born of mothers receiving
this compound for the maintenance of pregnancy
(20).
MEdHJnS
The experimental subjects were mostly institu-
tionalized mental defeetives. These included
prepuberal males and females, postpuberal males
and females, and aged females. Because of their
extremely small size, the sebaceous glands of the
prepuberal subject are exceedingly useful to
measure androgenic effects. We have determined
that this appendage is an exquisitely sensitive
androgenic target organ. As little as five milli-
grams of methyl testosterone orally per day
produces adult sized sebaeeous glands in a few
weehs (21).
It is known that sehum production is directly
proportional to sebaceous gland size (22, 23, 24).
Therefore, the sebaceous gland response has been
measured in two ways: (1) Histologic examination,.
and (2) gravimetric determination of sebum
produced per unit area per unit time (sebum
production). In the first instance, a biopsy speci-
men was taken from one cheek before the admini-
stration of the drug and from the contralateral
cheek afterwards. All the biopsy specimens were
serially sectioned and stained with hematoxylin
and eosin. The limitations of this procedure are
described elsewhere (25).
The method of determining sebum production
has been described before (24). In brief, the lipid
produced in a measured area on the forehead is
collected on absorbing papers held in place for
three hours. The amount of lipid collected on the
papers is then determined gravimetrically after
ether extraction.
In addition to natural progesterone admini-
stered intramuscularly, three synthetic progestins
FIG. 2. Structural formula of the progestins used in this study
Progesterone
Ethisterone
(I7-Ethynyl-testosterone)
17a-Ethynyl-19-nortestosterofle 17d-Hydroxyprogesterone 17-n-coproate
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were studied (Figure 2): 1) 17-ethynyltestosterone
given orally; 2) 17-alpha-ethynyl-19-nortestos-
terone given orally; and 3) alpha-hydroxyproges-
terone-17-n-caproate administered intramus-
cularly. These agents were given in the physiologic
or replacement dose range.
EXPERIMENTAL
1. Administration of Natural Progesterone (4
pregnene-3 ,20-dione)
a. Prepuberal Children. Four boys ranging in
age from nine to eleven years and four girls, ages
five to twelve years, who had no signs of pubertal
development were studied. Those with pubic
hair or more than rudimentary sehaeeous glands
were excluded. All of the boys and one girl
received 50 milligrams of progesterone intra-
muscularly daily for six to eight weeks; the other
three girls were given 50 milligrams of proges-
terone intramuscularly every other day for six
weeks. Sebaceous gland effects were evaluated
histologically.
Results. Only one subject developed slight
sebaeeous gland enlargement after treatment.
This was not deemed significant. No other signs
of androgenicity such as pubic hair, penile
enlargement, or voice change, were seen.
Comment. Because prepuberal individuals
respond to quite small amounts of testosterone
with sebaceous gland enlargement (21), these
negative results would indicate an absence of
androgenic effects for natural progesterone in
approximately physiologic amounts. As a matter
of fact, one of the above male subjects was
subsequently given testosterone and responded
promptly with sebaceous gland enlargement.
b. Postpuberal Subjects. Four postpubcral
males and seven postpubcral females, all less
than thirty years old received 50 milligrams of
progesterone intramuscularly daily for six to
seven weeks. All had moderate sized, adult
sebaceous glands. Histology was the method of
study.
Results. There was no change in glandular
size in any subject.
Comment. We would have anticipated a nega-
tive result even if progesterone did have signifi-
cant androgenic activity. We have previously
demonstrated that the sebaceous glands of the
postpuberal subject as a rule do not undergo any
important increase in size after testosterone
administration (21). The simple physiologic
explanation is that the glands have already
responded maximally to endogenous androgen.
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Fm. 3. Sebum production in three elderly postmenopausal females given 50mg. of progesterone intra-
muscularly daily. There is no change in sebum production.
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c. Aged Females. Three aged females were
given 50 milligrams of progesterone intramus-
cularly for seven weeks. Sebum production was
determined approximately weekly during treat-
ment.
Results. The output of sebum was not increased
in any subject (Figure 3).
Comment. Unlike the male, it has been thought
that the sebaceous glands of the female partially
regress in old age (26). Smith (7, 8) found that a
synthetic progestational agent (17-alpha-
hydroxyprogesterone-1 7-n-caproate) restored
glandular function in aged females. We were
unable to confirm this using progesterone as
above, or for that matter with the same proges-
tational agent as used by Smith as will be
subsequently shown. We have, however, demon-
strated an appreciable increase in sebum produc-
tion in aged females after the daily administra-
tion of 100 milligrams of methyl testosterone
(Figure 7—see section on 17-aipha-hydroxy-
progesterone-17-n-eaproate).
2. Administration of 1 7-alpha-ethynyl-19-nortes-
tosterone
Three prepuberal males, seven to ten years in
age, were given 20 milligrams of 17-alpha-
ethynyl-19-nortestosterone daily for twelve
weeks.
Results. In biopsy specimens taken at three,
eight and twelve weeks respectively, there was in
each case marked increase in glandular volume
as illustrated in Figure 4.
Comment. This synthetic progestin, 17-alpha-
ethynyl-19-nortestosterone caused prompt and
marked glandular enlargement in all three
subjects. Moreover, there was penile enlargement
and development of pubic hair as described else-
where (19). While the compound was given for
twelve weeks, a longer period than with other
compounds, the effects were evident long before
the end of the administration period. These
results substantiate the androgenicity previously
attributed to this compound (18).
FIG. 4. Effect of the daily administration of 20 mg. of 17-alpha-ethynyl-19-nortestosterone on the
sebaceous glands of the cheek of an 11 year-old prepuberal boy. A. Control specimen with small se-
baceous glands. B. After three weeks of drug administration the glands are now greatly enlarged. (Both
Aand B X 115).
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3. Administration of Ethisterone (1 7-ethynyl-
testosterone)
Three girls, eight to eleven years in age, without
pubic hair or other signs of puberty were given
100 milligrams of ethisterone daily for six weeks.
Three other girls, aged nine to eleven, two of
whom had slight pubic hair, were given 25 milli-
grams of ethisterone daily for seven weeks. The
effect on the sebaceous glands was judged
histologically.
Results. No subject experienced an increase in
sebaceous gland size. It should be noted that
three of the six received minimal amounts. One
of the girls receiving 100 milligrams of ethisterone
daily subsequently responded to methyl testos-
terone with good glandular enlargement.
Comment. This synthetic compound is not as
potent a progestational agent and is usually
given in higher dosages. It has also caused some
pseudohermaphrodism in female infants born of
mothers receiving the compound during preg-
nancy; however, it is apparently not as andro-
genie as 17-alpha-ethynyl-19-nortestosterone
(19). Perhaps with the more accurate gravimetric
method of assaying sebum, some androgenic
effect on the sebaceous glands would have been
detected.
Age 8
B. B.
Age 26
4. Administration of 1 7-alpha-hydroxyprogesterone-
1 7-n-ca proate
a. Post puberal Females. Four girls, eighteen to
thirty-two years in age, with normal cyclic
menstruation, were given 250 milligrams of this
compound intramuscularly weekly for ten weeks.
Sebum production was measured.
Results. As shown in Figure 5 none of these
females had any change in sebum production
measured at approximately weekly intervals.
Comment. As was anticipated postpuberal
individuals would not be expected to have any
increase in sebaceous gland size, even if a potent
androgen were given.
b. Aged Females. Six aged females were given
250 milligrams of 17-alpha-hydroxyprogesterone-
17-n-caproate intramuscularly weekly for eight
to ten weeks. The effect on the sebaceous glands
was determined by the gravimetric method.
Results. None of these females had any signifi-
cant increase in sebum production (Figure 6).
Comment. In contrast to the results of Smith
(7, 8), 17-alpha-hydroxyprogesterone-17-n-cap-
roate, like progesterone, had no effect on sebum
production. Three of the six females, subse-
quently given 100 milligrams of methyl testos-
terone daily, showed a significant increase in
sebum production. An example is given in
Figure 7.
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FIG. 5. Sebum production of four girls with normal cyclic menstruation. There is no change in sebum
production during 11 weeks administration of 250 mg. of 17-alpha-hydroxyprogesterone-17-n-caproate
weekly.
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Fin. 6. Sebum production of six elderly postmenopausal females given 250 mg. of 17-aipha-hydroxy-
progesterone-17-n-caproate intramuscularly weekly. There is no significant change in sebum production
during 7 to 10 weeks of drug administration.
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Fin. 7. Sebum production of a 72 year-old postmenopausal female given 250 mg. of 17-alpha-hydroxy-
progesterone-17-n-caproate intramuscularly weekly for 7 weeks and subsequently given 100 mg.
of methyl testosterone orally daily for eight weeks. There is an obvious increase in sebum production
with methyl testosterone.
5. &bum Production in Females with Normal every one to five days during at least one corn-
Menstrual Cycles plete cycle. Four were married and had children.
In six females, four of whom had premenstrual Results. As illustrated in Figure 8, there was
flares of acne, sebum production was determined no cyclic fluctuation in seburn production which
Stopped
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could be correlated with the menstrual cycle.
Sebum output does not change throughout the
cycle.
Comment. During the second half of the men-
strual cycle there is a significant rise in the total
urinary pregnandiol. This usually reaches a peak
around the twentieth day, reflecting the in-
creased production of progesterone by the newly-
formed corpus luteum; just before menstruation
the pregnandiol output decreases (27—29).
Investigators have reported cyclic rises in sebum
associated with this luteal phase of the menstrual
cycle (30, 31). This is tantamount to saying that
there is a rhythmic cycle of glandular increase
and decrease. Our results stand in conflict with
these reports; we cannot correlate scbum secretion
with the rhythmic changes in the endogenous
production of progesterone. Gland size, it may be
inferred from our data, is the same throughout
the cycle. Kalz and Scott's contrary claim is
based upon inspection of osmic acid stained
papers, a crude qualitative technic (30). In the
other report on the rise in sebum output the
technic of collection is not detailed, although the
impression is that the values represent lipid
recovered from the surface twenty-four hours
after defatting (31). In any case, in the chart
shown in this paper, the rise is complete by the
twelfth day of the cycle measured from the first
day of menstruation. This increase therefore,
takes place before the corpus luteum has formed,
and cannot be attributed to an increased pro-
duction of progesterone.
nJsCTJssION
Our results have consistently failed to show
that natural progesterone in approximately
physiological amounts has any effect on the size
or the output of the human sebaceous gland.
This finding conflicts starkly with increasing
reports of the growth stimulating influence of
progesterone on the sebaceous glands. We are
obliged to deny that endogenously secreted
progesterone has any androgenic effect. Only
Jarrett presents human experimental data to
support our viewpoint (30).
Animal studies have also generated conflicts.
Ebling found that progesterone did not have any
influence on the sebaecous glands of the normal
rat (33). On the other hand, Haskin, et al
(3), and Lasher, et at (4) found marked hyper-
plasia when progesterone was administered to
oophoreetomized rats. Minimal and questionably
significant changes followed the administration of
the low dose of one microgram daily. Glandular
enlargement occurred after the administration of
one milligram daily, a decidedly unphysiologic
dose. For a rat weighing 250 grams, this would
correspond to the huge amount of 280 milligrams
for a 70 kilogram human, perhaps five times the
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physiologic quantity. As cited earlier, very large
amounts of progesterone are known to have
androgenic effects in animals, causing enlarge-
ment of the prostate gland and seminal vesieles
(14—17). Two milligrams of progesterone daily
produced these changes in rats (15—17).
Female acne is the clinical problem most
directly affected by the possible androgenicity of
progesterone. In both males and females, adult
sebaceous glands are a prerequisite for the
development of acne in predisposed persons.
Until recently the hormonal control of this
enlargement in females was ascribed exclusively
to androgens elaborated by the adrenal cortex,
this being for all practical purposes the only
source of androgens. However, clinical derma-
tologists have sought to apply to humans the
demonstration of Haskin, Lasher and their
associates that large quantities of progesterone
produced sebaceous hyperplasia in oophorecto-
mized rats. If this were true for humans, proges-
terone would be an influential force in the
pathogenesis of female acne; indeed, this possi-
bility seems to have been warmly embraced as a
clinical fact, explaining particularly the pre-
menstrual flare of acne.
Moreover, this notion gains in appeal by the
light it sheds on another related question which
has come to be thought of as a considerable
paradox. Eunuchs with normal adrenal function
do not develop acne; and therefore, adrenal
androgens do not suffice to provide the hormonal
fuel for acne. But females, androgenically speak-
ing, are "eunuchs" and should not develop acne
either unless there is another source of androgens
besides the adrenals.
Ignoring the fact that hormones do not totally
account for the well known difference between
males and females, this type of reasoning is not,
in our opinion, conclusive. With the exception of
Hamilton's data on the absence of acne in a
comparatively small group of eunuchs (1), the
true incidence of acne in eunuchs has not been
evaluated by dermatologists. One would have to
examine eunuchs in the adolescent acne period.
After the twenties, acne becomes insignificant,
regardless of hormonal status. It is known that
some eunuchs may have beards and produce
sperm, presumably as a result of adrenal andro-
gens. For all we know, careful examination of a
large group of eunuchs in the acne age range
might disclose about the same amount of acne as
in women. Serious acne has a very much lower
incidence in females than males.
However, these are speculations. We should
like to cite what appears to be rather substantial
evidence that sebaceous gland development is
independent of the functioning corpus luteum.
We have had occasion to examine many prepu-
beral girls in respect to sebaceous gland develop-
ment and acne. It is the rule, not the exception,
that glandular enlargement takes place much
earlier than menstruation, often by one to two
years. Acne may occur in full force in adolescent
girls who have not menstruated at all. Yet prior
to the time of menarehe, the corpus luteum does
not form, and there is no significant progesterone
output by the ovary.
Zeligman and Hubener (6) reported the experi-
mental production of acne in adult females with
the administration of progesterone in dosages up
to 50 mg. daily for as long as 12 weeks. Histo-
logic study of specimens from the back were not
interpreted by them as showing any significant
increase in size. Nevertheless, the clinical results
were interpreted as indicating sebaceous gland
hyperfunction. Our own experience is different.
When large amounts of methyl progesterone are
given to females over long periods of time, we
have found it exceedingly difficult to produce
acne or cause a flare of active acne. It is the rare
case in which exogenous androgens will incite or
exacerbate acne in adolescents or adults. Most
authors do not appreciate that acne is a disease
with remarkable fluctuations.
SUMMARY
1. The effect of natural progesterone and
synthetic progestins on human sebaceous glands
has been investigated by histologic technics and
sebum production studies.
2. The administration of natural progesterone
in physiologic amounts to prepuberal males and
females, postpuberal males and females, and
aged females did not change sebaceous gland
size or function. Similarly, the administration of
two synthetic progestins, 17-ethynyltestosterone
and 1 7-alpha-hydroxyprogesterone- 17-n-caproate
to similar groups did not change the human
sebaceous glands.
3. On the other hand, in prepuberal males the
synthetic progesterone, 17-alpha-ethynyl-19-
nortestostcrone causes sebaceous gland enlarge-
ment and other androgenie effects of puberty.
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4. Sebum production does not fluctuate with
the cyclic changes of the menstrual cycle.
5. Physiological amounts of progesterone
have no influence on the human sebaeeous
glands. It would therefore follow that female
acne is not materially influenced by the effect of
endogenous progesterone on the sebaceous
glands.
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DISCUSSION
DR. J. GRARAM SMITH, JR. (Miami, Florida):
Dr. Strauss and I agree that the prepubertal girl
has a very low level of sebaceous excretion, the
adolescent has a higher level of sebaceous excre-
tion, and the elderly female has a low level. If
progestational hormones have little or no
influence on sebaceous excretion, as his studies
indicate, what does cause these aging changes on
the human female sebaceous gland?
Dn. ALLAN L. LonsNcx (Chicago, Ill.): I
believe that the methods available for quantita-
tively measuring sebaceous secretion or sebaceous
glandular activity in man are, at best, of contro-
versial reliability and tend to reflect only rather
gross changes.
The difficulties of methodology become even
more hazardous in studies involving only small
numbers of individuals. For this and other
reasons it is difficult to compare the results
reported here with the results of endoerinologic
experiments on sebaceous glands that our group
at the University of Chicago has carried out in
castrated rats. In such adult rats, testosterone
was, of course, a considerably more potent stimu-
lator of sebaceous glands than progesterone.
In man with the relatively insensitive methods
available the probably lesser sebaceous stimulat-
ing effect of progesterone might not readily be
picked up especially when non-castrated adult
individuals are studied in whom endogenous
progesterone may already be exerting a consider-
able stimulating effect so that a true base-line
for comparison is not available. The failure to
observe progesterone-induced sebaceous stimu-
lation in prepubertal girls is not surprising as
similar lack of such effect occurs in prepubertal
rats. Possibly there is a deficiency of pituitary
sebotropic factor prepubertally which accounts
for the failure to respond.
DR. VICTOR U. WHEATLEY (Palo Alto, Calif.):
I have worked quite extensively on this question
of the determination of sebum levels. It is ex-
tremely difficult and my personal feeling is that
the method of Miescher and Schonberg, is unsatis-
factory. I prefer to extract the lipids from a
measured area of skin in a cup and determine
them gravimetrically. Even with this technic you
still get very wide day to day variations, making
the interpretation of the results somewhat
difficult. Nevertheless we obtained evidence
indicating changes during the menstrual cycle: a
lowering just before the onset of ovulation and
an increase after ovulation. This has been con-
firmed by other workers.
DR. STEPHEN ROTRMAN (Chicago, Ill.): While
I realize that hormonal effects cannot be com-
pared on a milligram per milligram basis I still
wonder why the authors have used 100 mg.
of testosterone and only 50 mg. of progesterone
when they tried to compare the effect.
Dn. EUGENE J. VAN SCOTT (Bethesda, Md.):
I would like to ask Dr. Strauss if he knows of any
correlation of sebaceous gland size and sebum
output. Does a large gland produce more sebum,
in proportion to its size, than a small gland?
Dn. THOMAS B. FITZPATRICK (Boston Mass.):
About three years ago I used 19-norethinyl-
testosterone in three males and three females with
severe cystic acne. The results were rather
definite and impressive, although I did not per-
form a double blind trial. I understand that
Sulzberger has noted a similar improvement with
this drug in cystic acne. What has been your
experience?
CAPTAIN CHARLES G. MRNnELSON (Fort
Jackson, S. C.): Not having worked with hor-
mones, I would like to ask a question about the
clinical side. This is in reference to your work
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and the effectiveness of agents in acne vulgaris
presented in Chicago last December. Do you
have any evidence of what evidence is there of a
change in glandular size with the nse of chioro-
thiazide and similar compounds that seem to
have some clinical effect pre-menstrually? Is
there a change in the size of the gland or some
other effect not related to sodium and water
balance which accounts for improvement?
DE. JOHN S. S'rEAuss (in closing): Dr. Smith,
this is a loaded question which you asked me
earlier in the day and know that I cannot answer.
I can only offer some theoretical ideas. Talbot,
et at, (Talbot, N. B., Sobel, E. II., MacArthur,
J. W. and Crawford, J. D.: Functional Endo-
crinology From Birth Through Adolescence,
Commonwealth Fund, 1952) has proven that
there is an adrenarchc similar to menarche. At the
time of adrenarchc, which usually precedes
mcnarche by one to two years, adrenal output
increases markedly. The increased androgenic
adrenal hormones may stimulate the sebaceous
glands. Whether a decrease in adrenal activity
occurs in old age is not certain.
In answer to Dr. Lorincz's and Dr. Wheatlcy's
inquiries as to the methodology, its validity is
detailed elsewhere. (Strauss, J. S. and Pochi,
P. E.: The quantitative gravimctric determina-
tion of sebum production, J. Invest. Derm., 36:
293—298, 1961) When a large group of individ-
uals was followed with repeated testing over the
year and a half that we have been doing these
tests, the sebum production was relatively
constant. In the evaluation of the hormone
effects each individual serves as his own control
and the interpretation is dependent on a series of
tests, not on a single test. The changes that have
been illustrated arc definitely real.
Dr. Rothman, the chart concerning testos-
terone has been presented just as an illustration
of the changes that can be expected. In experi-
ments in which serial sections of biopsies taken
from the cheek before and after the daily ad-
ministration of only 5 mg. of methyl testosterone
to prepuberal children were studied, there was
a definite increase in sebaceous gland size.
These studies are to be repeated utilizing sebum
production as an end-point.
Dr. Van Scott, our studies, as well as those of
Mieseher and Schonberg (Acad. Med. Wissensch
1: 101—114, 1941) and Kligman and Shelley
(J. Invest. Dermat. 30: 99—125, 1958) demon-
strate the reliability of measuring variation in
glandular size by the changes in sebum
production.
In answer to Dr. Wheatley concerning the
changes in sebum production during the men-
strual cycle the rise illustrated in your article,
(Hodgson-Jones, I. S., MacKenna, R. M. B. &
Wheatley, V. R.: Acta Dermat.-venereol. 32:
Supp. 29, 155—161 1952), occurred by the 12th
day of the cycle measured from the onset of
menses. Most likely this is before the corpus
luteum, which secretes progesterone, forms.
Dr. Fitzpatrick, we have not treated any
patients with acne with Norlutin.
Dr. Mendelson, a few studies done with
Diuril have not disclosed any changes in sebum
production or glandular size by biopsy section.
